US Corporate Distress Financial Stress SEC Filings — February 22, 2026

23-02-2026

MoonLake Immunotherapeutics filed a Form 8-K on February 23, 2026 (AccNo: 0001213900-26-018967), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating several material corporate developments, but specific transaction details, financial metrics, dollar values, and impacts are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or named entities beyond the filer are provided.

23-02-2026

AppTech Payments Corp. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

23-02-2026

Barinthus Biotherapeutics plc filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are provided in the filing summary.

23-02-2026

Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 23, 2026, reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the modifications, amendments, disclosures, or exhibits are provided, resulting in no quantifiable positive or negative metrics. This multi-item filing appears informational without disclosed financial or operational impacts.

23-02-2026

BullFrog AI Holdings, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, with potential transfer of listing. Item 9.01 reports financial statements and exhibits. No quantitative financial metrics, transaction values, or further details on the delisting rationale or impacts are disclosed.

23-02-2026

Illinois Tool Works Inc filed a multi-item 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 1.02 termination of a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. The filing reflects both new commitments and the end of prior ones alongside additional financial obligations. No specific transaction details, values, or impacts are disclosed.

23-02-2026

Ovintiv Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific terms, values, financial impacts, or other metrics are disclosed in the available filing summary.

23-02-2026

Gilead Sciences, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No details on the nature of the agreement, transaction value, financial impacts, or other quantitative metrics are disclosed. This is a multi-item mandatory filing for Items 1.01 and 9.01 with Item 7.01 often accompanying forward-looking disclosures.

• ·AccNo: 0001104659-26-018314

23-02-2026

PENN Entertainment, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, personnel changes, disclosures, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

23-02-2026

United Homes Group, Inc. filed a Form 8-K on 2026-02-23 reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No quantitative financial metrics, transaction values, positive or negative performance indicators, or period-over-period comparisons are disclosed. This is a multi-item informational filing with no specified directional impacts.

23-02-2026

ADC Therapeutics SA filed a Form 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific details on the agreement terms, transaction value, share counts, or financial impacts are provided in the filing summary. This represents a multi-item mandatory disclosure with no quantitative metrics or performance comparisons disclosed.

23-02-2026

Resolute Holdings Management, Inc. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a new material definitive agreement, under Item 1.02 termination of a prior material definitive agreement, and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the nature of the agreements, transaction values, parties involved, or financial terms were provided. This multi-item filing signals significant contractual changes including both a new commitment and termination of an existing one, but lacks quantification of impacts.

23-02-2026

The company filed a multi-item Form 8-K on February 23, 2026 (AccNo: 0001104659-26-018349), disclosing entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). Specific details including parties involved, transaction values, personnel changes, amendment descriptions, or financial impacts are NOT_DISCLOSED in the provided information. This simultaneous reporting of entry and termination of material agreements alongside governance and leadership changes suggests potentially offsetting developments, but lacks quantification for assessment.

23-02-2026

GameSquare Holdings, Inc. filed a Form 8-K on February 23, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, financial metrics, or quantitative impacts provided. No positive or negative performance metrics are disclosed.

23-02-2026

CULP INC filed an 8-K on 2026-02-23 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No financial metrics, transaction values, or period-over-period comparisons were disclosed.

23-02-2026

Candel Therapeutics, Inc. filed an 8-K on February 23, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, financial impacts, or events were provided in the filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or directional indicators disclosed.

23-02-2026

VisionWave Holdings, Inc. filed an 8-K on 2026-02-23 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, parties, or financial impacts provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons were disclosed.

23-02-2026

Atara Biotherapeutics, Inc. filed a Form 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure filing with no specific transaction details, dollar values, share counts, financial metrics, or period-over-period comparisons provided. No positive or negative metrics are disclosed, preventing assessment of financial impacts or strategic outcomes.

23-02-2026

Verisk Analytics, Inc. filed a Form 8-K on February 23, 2026, reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or disclosures provided in the summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

23-02-2026

Fortress Biotech, Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 8.01 reports other events, and Item 9.01 lists financial statements and exhibits. No specific transaction values, financial impacts, or quantitative metrics are disclosed.

23-02-2026

BrightSpire Capital, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided information. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

23-02-2026

Cannabist Co Holdings Inc. filed a Form 8-K on 2026-02-23 under Item 1.01 disclosing entry into a material definitive agreement. No details on the agreement's parties, terms, dollar value, strategic rationale, or financial impacts are provided in the available information. No quantitative metrics, comparisons, or scheduled events are mentioned.

• ·Accession Number: 0001776738-26-000006
• ·File Size: 131 KB
• ·Single-item filing (Item 1.01 only)

23-02-2026

TRANSUITE.ORG INC. filed a Form 8-K on 2026-02-23 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No details on the agreement terms, counterparties, value, or financial impacts are disclosed.

23-02-2026

Avenue Therapeutics, Inc. filed an 8-K on 2026-02-23 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

23-02-2026

NEXTNRG, INC. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed.

23-02-2026

Arcellx, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement's nature, parties, terms, dollar value, or financial impacts. No quantitative metrics, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.

23-02-2026

Functional Brands Inc. filed an 8-K on 2026-02-23 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, transaction values, dollar amounts, percentages, or financial impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

23-02-2026

Sharps Technology Inc. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, transaction values, dollar amounts, names of individuals or counterparties, financial impacts, or quantitative metrics were provided in the filing summary. This represents a multi-item mandatory filing with unknown implications due to lack of disclosed substance.

23-02-2026

SI-BONE, Inc. filed a Form 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.02 results of operations and financial condition, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. This is a multi-item filing covering significant corporate, financial, and personnel developments. No specific transaction details, financial metrics, personnel names, dollar values, or performance comparisons are disclosed.

23-02-2026

VEEA INC. filed an 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No transaction details, dollar values, parties involved, financial impacts, or other metrics are disclosed.

23-02-2026

Angel Studios, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's terms, parties, dollar value, or financial impacts are disclosed in the filing summary. No quantitative metrics, positive or negative changes, or operational effects are mentioned.

23-02-2026

Houston American Energy Corp filed an 8-K on February 23, 2026 (AccNo: 0001493152-26-007761), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, share counts, dollar amounts, or financial impacts were disclosed. This multi-item filing indicates potential strategic or financing developments but provides no specifics for impact assessment.

• ·File size: 932 KB
• ·Multi-item mandatory 8-K filing

23-02-2026

Lunai Bioworks Inc. filed a Form 8-K on 2026-02-23 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, effective dates, or exchange involved were disclosed. This represents a material negative event with no offsetting positive information provided.

• ·AccNo: 0001731122-26-000282
• ·Filing size: 190 KB
• ·Sector: NOT_DISCLOSED

23-02-2026

Reborn Coffee, Inc. filed an 8-K on 2026-02-23 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No financial metrics, transaction values, or quantitative impacts were disclosed in the provided filing summary. This represents a multi-item filing focused on significant regulatory and leadership events.

23-02-2026

Village Farms International, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial metrics, positive or negative impacts, or other quantitative data are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

International Battery Metals Ltd. filed a Form 8-K on February 23, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, accompanied by exhibits under Item 9.01. This multi-item mandatory filing highlights significant corporate actions, where the material agreement represents a potentially strategic development while the unregistered equity sales introduce potential shareholder dilution. No specific transaction values, financial impacts, or other quantitative details are provided.

23-02-2026

Algorhythm Holdings, Inc. filed a multi-item Form 8-K on February 23, 2026, reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, terms, financial impacts, or quantitative metrics were disclosed. This filing appears informational without detailed positive or negative elements.

23-02-2026

I-ON Digital Corp. filed a Form 8-K on February 23, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This multi-item filing highlights potentially significant corporate actions but lacks specifics on positive or negative implications.

23-02-2026

Twin Vee PowerCats, Co. filed a Form 8-K on February 23, 2026 (AccNo: 0001731122-26-000283), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific details provided on the agreement, events, transaction terms, financial impacts, or metrics. No quantitative data, period-over-period comparisons, positive or negative metrics, or scheduled events are disclosed.

23-02-2026

Enhabit, Inc. filed a Form 8-K on 2026-02-23 disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, but specific details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, guidance changes, or scheduled events are mentioned.

23-02-2026

Better Home & Finance Holding Co filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details including transaction value, parties, terms, financial impacts, or strategic context are disclosed.

23-02-2026

Keurig Dr Pepper Inc. filed a Form 8-K on 2026-02-23 (AccNo: 0001193125-26-064353, Size: 2 MB) reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific transaction details, financial metrics, dollar values, or period-over-period comparisons provided in the summary. No positive or negative quantitative impacts are disclosed.

• ·Filing Accession Number: 0001193125-26-064353
• ·Filing Size: 2 MB

23-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, or exhibits are disclosed. No financial metrics, positive or negative changes, or quantitative impacts are mentioned.

23-02-2026

OLB Group, Inc. filed an 8-K on February 23, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no quantitative details on transaction values, financial impacts, or strategic implications disclosed in the provided information. No revenue, earnings, balance sheet effects, or guidance changes are mentioned.

23-02-2026

Vir Biotechnology, Inc. filed a multi-item Form 8-K on February 23, 2026, reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, dollar values, share counts, or period-over-period comparisons are disclosed. The filing indicates potentially significant developments but provides no quantitative data for impact assessment.

23-02-2026

AMC Networks Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics (positive, negative, or flat) are disclosed. This multi-item filing signals a potentially significant development, but lacks quantitative data for assessment.

23-02-2026

HA Sustainable Infrastructure Capital, Inc. filed an 8-K on 2026-02-23 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are provided.

23-02-2026

Empire Petroleum Corp filed an 8-K on 2026-02-23 disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 2.03 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No quantitative transaction values, financial impacts, or strategic details are disclosed. This is a multi-item mandatory filing with no specified positive or negative metrics.

23-02-2026

TCW Strategic Income Fund Inc filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 8.01 Other Events. No specific details regarding the nature of the agreement, transaction size, financial impacts, or other quantitative metrics are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure with no period-over-period comparisons or named entities beyond the filer mentioned.

23-02-2026

Lument Finance Trust, Inc. filed an 8-K on February 23, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or other metrics are provided.